It may only be a matter of time until expectant mothers can monitor the heartbeats of their unborn child from home with medtech company HeraMed (ASX: HMD) pursuing regulatory reclassification to enable their HeraBEAT device to be reinstated for commercial distribution. HeraMED is advancing discussions with the Therapeutic Goods Administration (TGA) to reinstate its HeraBEAT
Read More
Medical data and technology company HeraMED (ASX: HMD)’s subsidiary HeraCARE is gearing up for its soft launch with Telstra. It will soon be available to medical practices using Telstra Health’s MedicalDirector patient management software. In November 2023, HeraMED initially announced its partnership with Telstra Health’s MedicalDirector platform, which serves GPs and healthcare professionals. HeraCARE is
Read More
Making maternity care more accessible to all expectant parents including those in regional and rural Australians, HeraMED (ASX: HMD) has been promoting at-home pregnancy management using its digital monitoring device HeraCARE. Now the Company has levelled up its strategic shift for the device by securing a new Partner Agreement with Telstra Health, expanding its customer
Read More
Whilst the Government might be making (and subsequently reneging on) policy around prenatal care and IVF visits due to COVID, one company is actually making positive strides ahead. Medical data and technology company HeraMED (ASX: HMD) is readying themselves for a full commercial rollout of HeraCARE, their prenatal and foetal health monitoring system to expectant
Read More
With the rapid acceleration of telehealth solutions brought about by the pandemic, one company is uniquely servicing a key demographic- expectant mothers. Medtech HeraMED (ASX: HMD) is moving obstetric care into 2021 with their comprehensive digital health platform, HeraCARE and associated fetal and maternal heart rate monitor, HeraBEAT. The clinically validated tech allows for remote
Read More
Medical data and technology company HeraMED (ASX: HMD) has today announced a partnership to accelerate their mission to revolutionise maternal care. The Company has entered into a paid pilot with Obstetrix Medical Group, one of the largest clinical providers in the US for both women’s and children’s health. Obstetrix, an affiliate of US $2.2 billion
Read More